Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01723709 · ClinicalTrials.gov registry record
The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
A clinical trial of Multiple Sclerosis, sponsored by Duke University.
- Completed
- Registry status
- 973
- Enrollment target
- 5
- Study locations
NCT01723709 is a study of Multiple Sclerosis that has completed, run by Duke University. The registered enrollment target is 973 participants, above the 582-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (67% higher). The trial reports 5 study locations across 1 state.
The verdict
NCT01723709, a study of Multiple Sclerosis, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 973 participants
- Enrollment target
- 5
- Study locations
Study Summary
The goal of this study is to enroll 1000 participants with a history of Multiple Sclerosis into the MURDOCK Study (Duke IRB Pro00011196) as well as into the Multiple Sclerosis Cohort study (Duke IRB Pro00023791). All 1000 participants will answer a 4-page questionnaire administered by a trained study coordinator which is designed to collect information on the participant's diagnosis of Multiple Sclerosis. The goal of the study is to seek genetic explanations for response to treatment, progression of the disease, and biomarker validation.
Conditions Studied
Study Locations (5)
North Carolina
- Carolinas Medical Center Northeast Medical Arts Building - Concord
- Ada Jenkins Center - Davidson
- The Stedman Center on the Duke Center for Living Campus - Durham
- Kannapolis Internal Medicine - Kannapolis
- Raleigh Neurology Associates - Raleigh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 973 participants |
| Start Date | 2010-06 |
| Est. Completion | 2017-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01723709
The ClinicalTrials.gov registry entry for NCT01723709 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 973 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 582-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (67% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.
NCT01723709 reports 5 study locations spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT01723709 about?
NCT01723709 is a clinical study titled "The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort". The goal of this study is to enroll 1000 participants with a history of Multiple Sclerosis into the MURDOCK Study (Duke IRB Pro00011196) as well as into the Multiple Sclerosis Cohort study (Duke IRB Pro00023791). All 1000 participants will answer a 4-page questionnaire administered by a trained stud...
What is the current status of trial NCT01723709?
This trial is currently completed. The enrollment target is 973 participants. The study started on 2010-06. Estimated completion is 2017-05.
What conditions does trial NCT01723709 study?
This clinical trial studies the following conditions: Multiple Sclerosis.
Who is sponsoring clinical trial NCT01723709?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01723709 being conducted?
This trial has 5 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Vancomycin Study in Multiple Sclerosis (MS)
RECRUITING · Phase 1
-
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
RECRUITING
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.